These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 4063911)

  • 1. Transdermally administered scopolamine.
    Paasuke RT
    CMAJ; 1985 Nov; 133(10):956. PubMed ID: 4063911
    [No Abstract]   [Full Text] [Related]  

  • 2. Transdermal scopolamine intoxication in a child.
    Klein BL; Ashenburg CA; Reed MD
    Pediatr Emerg Care; 1985 Dec; 1(4):208-9. PubMed ID: 3842169
    [No Abstract]   [Full Text] [Related]  

  • 3. Transdermal scopolamine in motion sickness.
    Cronin CM; Sallan SE; Wolfe L
    Pharmacotherapy; 1982; 2(1):29-31. PubMed ID: 6927209
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Scopolamine plaster caused hallucination. Toxic psychosis in a 10-year-old boy caused by an agent against motion sickness].
    Björk M; Wettergren B
    Lakartidningen; 1995 Feb; 92(7):638. PubMed ID: 7861858
    [No Abstract]   [Full Text] [Related]  

  • 5. Accidental mydriasis from scopolamine patches.
    Rosen NB
    J Am Optom Assoc; 1986 Jul; 57(7):541-2. PubMed ID: 3745760
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of TTS-scopolamine, dimenhydrinate, lidocaine, and tocainide on motion sickness, vertigo, and nystagmus.
    Pyykkö I; Padoan S; Schalén L; Lyttkens L; Magnusson M; Henriksson NG
    Aviat Space Environ Med; 1985 Aug; 56(8):777-82. PubMed ID: 3929760
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [An unusual case of psychosis caused by long-term administration of a scopolamine membrane patch. Paranoid hallucinogenic and delusional symptoms].
    Rubner O; Kummerhoff PW; Haase H
    Nervenarzt; 1997 Jan; 68(1):77-9. PubMed ID: 9132625
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of transdermally administered scopolamine in preventing motion sickness.
    McCauley ME; Royal JW; Shaw JE; Schmitt LG
    Aviat Space Environ Med; 1979 Nov; 50(11):1108-11. PubMed ID: 393242
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transdermal scopolamine for motion sickness.
    Med Lett Drugs Ther; 1981 Oct; 23(21):89-90. PubMed ID: 7027000
    [No Abstract]   [Full Text] [Related]  

  • 10. Transdermal scopolamine psychosis.
    Osterholm RK; Camoriano JK
    JAMA; 1982 Jun; 247(22):3081. PubMed ID: 7077797
    [No Abstract]   [Full Text] [Related]  

  • 11. Transdermal scopolamine in the prevention of motion sickness: evaluation of the time course of efficacy.
    Homick JL; Kohl RL; Reschke MF; Degioanni J; Cintron-Trevino NM
    Aviat Space Environ Med; 1983 Nov; 54(11):994-1000. PubMed ID: 6651736
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Psychosis due to transdermally administered scopolamine.
    MacEwan GW; Remick RA; Noone JA
    CMAJ; 1985 Sep; 133(5):431-2. PubMed ID: 4027811
    [No Abstract]   [Full Text] [Related]  

  • 13. Prevention of experimental motion sickness by scopolamine absorbed through the skin.
    Graybiel A; Knepton J; Shaw J
    Aviat Space Environ Med; 1976 Oct; 47(10):1096-100. PubMed ID: 791234
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transdermal scopolamine-induced psychosis.
    Ziskind AA
    Postgrad Med; 1988 Sep; 84(3):73-6. PubMed ID: 2901077
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transdermal therapeutic system scopolamine (TTSS), dimenhydrinate, and placebo--a comparative study at sea.
    Noy S; Shapira S; Zilbiger A; Ribak J
    Aviat Space Environ Med; 1984 Nov; 55(11):1051-4. PubMed ID: 6508687
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transdermal scopolamine delivery system (TRANSDERM-V) and acute angle-closure glaucoma.
    Hamill MB; Suelflow JA; Smith JA
    Ann Ophthalmol; 1983 Nov; 15(11):1011-2. PubMed ID: 6651138
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Toxic psychosis from transdermal scopolamine in a child.
    Sennhauser FH; Schwarz HP
    Lancet; 1986 Nov; 2(8514):1033. PubMed ID: 2877187
    [No Abstract]   [Full Text] [Related]  

  • 18. [A draftee got a CNS disorder after treatment with scopolamine plaster].
    Olevik P
    Lakartidningen; 1987 Apr; 84(17):1463. PubMed ID: 3586788
    [No Abstract]   [Full Text] [Related]  

  • 19. Scopolamine psychosis revisited.
    Cairncross JG
    Ann Neurol; 1983 May; 13(5):582. PubMed ID: 6870212
    [No Abstract]   [Full Text] [Related]  

  • 20. [Intoxication psychosis following the administration of scopolamine drops into the conjunctival sac].
    Krynyckyj V; Janovský F; Sedivec V
    Cesk Psychiatr; 1966 Dec; 62(6):405-8. PubMed ID: 5980803
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.